tiprankstipranks

Herwig Janssen Insider Profile

4 Followers
Herwig Janssen, Director at Tryptamine Therapeutics, holds 37.88M shares in Tryptamine Therapeutics (Ticker: AU:ENP).
tipranks
Herwig  Janssen

Herwig Janssen
Tryptamine Therapeutics (ENP)
Director

Not Ranked
Herwig Janssen has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

AU$1M
100.00%
A breakdown of Herwig Janssen's holdings

Insider Roles

Tryptamine Therapeutics
(ENP)
Director
Roles that Herwig Janssen holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Herwig Janssen

Herwig Janssen's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Tryptamine Therapeutics
Apr 20, 2026
Director
Uninformative Buy
24.98K
AU$1.36M
Herwig Janssen has not reported any informative transactions for AU:ENP, therefore, performance cannot be measured.
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jan 16, 2026
Uninformative Buy
AU$64.11K
1,931,012
AU$0.03
Apr 20, 2026
Uninformative Buy
AU$24.98K
726,195
AU$0.03
List of latest transactions for each holding click on a transaction to see Herwig Janssen's performance on stock

Herwig Janssen insider profile FAQ

What is the percentage of profitable transactions made by Herwig Janssen?
The percentage of profitable transactions made by Herwig Janssen is ―.
    What is the average return per transaction made by Herwig Janssen?
    The average return per transaction made by Herwig Janssen is ―.
      What stocks does Herwig Janssen hold?
      Herwig Janssen holds: AU:ENP stocks.
        What was Herwig Janssen’s latest transaction?
        Herwig Janssen latest transaction was an Uninformative Buy of AU$24.98K.
          What was Herwig Janssen's most profitable transaction?
          Herwig Janssen’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Herwig Janssen's role in Tryptamine Therapeutics?
            Herwig Janssen's role in Tryptamine Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.